Transfection Reagents and Equipment Market - Emerging Industry Dynamics | Global Future Forecasts

This report aims to provide insights into the global Transfection Reagents and Equipment Market. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Target Audience for this Report:

# Biopharmaceutical companies

# Biotechnology companies

# Transfection equipment, reagent, and kit manufacturing companies

# Suppliers and distributors of transfection reagents

# Research institutes

# Academic centers

# Venture capitalists

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139141146

Factors Influencing Global Growth:-

This growth can be attributed to factors such as advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer.

Moreover, development of large scale transfections, rising demand of protein therapeutics, and emerging markets across India and China are likely to create opportunities for players operating in the market.

Restraints:

# Selective Effectiveness of Transfection Reagents

# Home Brew Reagents Restrict Sale of Commercial Kits

# High Cost of Transfection Reagents

Opportunities:

# Large-Scale Transfections

# High-Growth Opportunities in Asian Market

Challenges:

# Transfection in Hard-To-Transfect Cells

# Cytotoxicity in Transfection - A Major Concern

Monetary Growth Expectations, Globally:

This report studies the global transfection reagents and equipment market from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.

Geographical Growth Scenario:

On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.

Read More:

https://www.marketsandmarkets.com/Market-Reports/transfection-reagents-equipment-market-139141146.html

Leading Market Players:

# Thermo Fisher Scientific Inc. (U.S.)

# Promega Corporation (U.S.)

# Hoffmann-La Roche Ltd. (Switzerland)

# QIAGEN N.V. (Netherlands) and many more…

Players operating in the transfection reagents and equipment market adopted strategies such as agreements, collaborations, and partnerships to strengthen their global presence.

Global Protein Assays Research Industry to Witness Remarkable Growth in Next FIVE Years..!

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

This report also aims to provide insights into the global protein assays market. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Target Audience for this Report:

# Protein assay manufacturers and vendors

# Distributors of protein assays

# Various research and consulting companies

# Associations related to pharmaceutical and biotechnological research

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547

Factors Influencing Global Growth:-

# Increasing Pharmaceutical and Biotech R&D Expenditure

# Favorable Government Funding Scenario for Proteomics Research

Restraints:

# High Cost of Multiplex Assay Equipment

# Sequestration Cuts in the U.S.

Opportunities:

# Emerging Markets

# Biomarker Identification

Challenges:

# Dearth of Skilled Professionals

# Issues Related to the Development of Protein Assays for Various Disease Types

Monetary Growth Expectations, Globally:

The protein assays market is expected to be valued at USD 1.42 Billion in 2017 and is projected to grow at a CAGR of 11.1% between 2017 and 2022, to reach USD 2.41 Billion in 2022.

Geographical Growth Scenario:

Based on region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).

However, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China, India, and Japan; the increasing R&D expenditure in life science, and increasing private-public partnerships for proteomics research are some major factors driving the growth of this regional segment.

Read More: 

https://www.marketsandmarkets.com/PressReleases/protein-assay.asp

Leading Market Players:

# Thermo Fisher Scientific (U.S.)

# Bio-Rad Laboratories, Inc. (U.S.)

# Merck KGaA (Germany)

# Cell Signaling Technology, Inc. (U.S.)

# General Electric Company (U.S.)

# PerkinElmer Inc. (U.S.). and many more…

The growth of the protein assays market can be attributed to the increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research. Based on the analysis of strategic developments undertaken by market players between 2014 and 2017, the key strategy followed by most companies in the market is expansions and agreements, partnerships, and collaborations.

Thermo Fisher Scientific was leading player in the protein assay products market in 2016. The company focuses on organic and inorganic strategies in order to strengthen its position in the market. In 2015, the company acquired Alfa Aesar (U.S.), and in 2014 acquired Life Technology Corporation (U.S.) these acquisitions helped the company strengthen its protein assays product portfolio. In 2017, the company acquired Core Informatics (U.S.) and in 2016 acquired Affymetrix (U.S.) in order to enhance its share in the market.

Merck KGaA was another leading player in the protein assay products market in 2016. It focuses mainly on collaborations, acquisitions, and expansions to strengthen its position in the market. In November 2015, the company acquired Sigma Aldrich (U.S.). This acquisition helped it to increase its product portfolio and its geographic presence. The company also focuses on expansions to strengthen its market share.

Patent Expiries to Boost the Demand for Drug Discovery Services | It's Impact on Global Pharma Industry

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies in the global Drug Discovery Services Industry.

Objectives of the Study: 

# To define, describe, segment, and forecast the market on the basis of process, type, drug type, therapeutic area, and region

# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restrains, opportunities, and burning issues)

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders

# To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

# To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies

# To track and analyze competitive developments such as agreements, partnerships, acquisitions, in the market

Target Audience for this Report:

# Research Institutes

# Pharmaceutical and Biotechnological Companies

# Venture Capitalists and Investors

# Contract Research Organizations (CROs)

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138732129

Factors Influencing Global Industry Growth:-

The major factors driving the growth of this market are increasing research and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, and increasing demand for outsourcing of analytical testing and clinical trial services.

Restraints:
# High Cost of Drug Discovery and Development

# Stringent Regulations Governing Drug Discovery, and Animal Usage

Key Market Opportunities:

# Introduction of Advanced Technologies

# Patent Expiries to Boost the Demand for Drug Discovery

Industry’s Revenue Growth Expectations:

The drug discovery services market is expected to reach USD 14.40 Billion by 2022 from USD 8.32 Billion in 2017, at a CAGR of 11.6%.

Geographical Growth Scenario:

Asia Pacific to offer lucrative growth opportunities for players operating in the market

By region, the global drug discovery services market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America is expected to account for the largest share of the market. On the other hand, Asia Pacific is expected to grow at the highest CAGR during the forecast period. The high growth rate of this market is attributed to less stringent regulations and economical manufacturing costs in APAC.

Read More: 

https://www.marketsandmarkets.com/PressReleases/drug-discovery-services.asp

Leading Market Players:

# Albany Molecular Research Inc. (AMRI) (US)

# Charles River Laboratories International (US)

# Evotec (Germany)

# GenScript (US)

# Covance (US)

# WuXi AppTec (China) and many more…

Expansions, partnerships, agreements, and collaborations were the key strategies followed by players in the drug discovery services market. Some of the leading players that adopted this strategy include Charles River Laboratory (US), Evotec (Germany), Domainex (UK), GenScript (US), and Covance (US).

Advanced Proteomics Research Technologies - A Major Boon to the Global Genomics Industry

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Objectives of the Study:

# To define, describe, segment, and forecast the global proteomics market by instrumentation technology, reagent, services and software, application, end user, and region.

# To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the proteomics market in five main regions along with their respective key countries (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa)

# To profile key players in the global proteomics market and comprehensively analyze their core competencies and market shares

# To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, & agreements; and R&D activities of the leading players in the proteomics market

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

Recent Developments:

# In 2018, Thermo Fisher Scientific, Inc. and Symphogen formed a collaboration under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap LC/MS/MS system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.

# In 2018, Thermo Fisher Scientific, Inc. launched TSQ Fortis Triple Quadrupole Mass Spectrometer and UHPLC-MS Ultrapure Solvents.

# In 2018, Agilent Technologies acquired Advanced Analytical Technologies, Inc. to enhance its technology base and provide a comprehensive set of solutions for NGS workflows.

# In 2017, Merck KGaA signed an MoU with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development. Under the agreement, Merck would supply Mobius single-use systems, cell line, cell culture media, and chromatography to accelerate the development of biologic drugs.

Critical questions answered in the report:

# How will the current technological trends affect the proteomics market in the long term?

# How is the service market for proteomics moving?

# What are the application areas of the market?

# Which regions are likely to grow at the highest CAGR?

# What are the growth strategies being implemented by major market players?

Factors Influencing Global Industry Growth:-

Growth in this market is driven by increasing research activity in the area of personalized medicine and drug discovery, increasing R&D expenditure by the pharmaceutical and biotechnology sector, and rising government funding for proteomics.

Restraints:

# High Cost of Instruments

Key Market Opportunities:

# Growing Prominence of Nanoproteomics - the Convergence of Nanotechnology and Proteomics

# Personalized Proteomics for Precision Health

# High Growth Opportunities in Emerging Countries

Challenges:

# Data Management in Proteomics Research

# Low Biomarker Discovery-To-Approval Ratio

Industry’s Revenue Growth Expectations:

The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.

Geographical Growth Scenario:

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Read More: https://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html

Leading Market Players:

# Thermo Fisher Scientific, Inc. (US)

# Agilent Technologies, Inc. (US)

# GE Healthcare (US)

# Bio-Rad Laboratories, Inc. (US)

# Danaher Corporation (US)

# Luminex Corporation (US) and many more…

This is How the Cloud Computing is Transforming the Global Healthcare Industry

This study involved four major activities in estimating the current size of the Healthcare Cloud Computing Market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Recent Developments:

# To define, describe, and forecast the global market by application, deployment model, pricing model, service model, component, end user, and region

# To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders

# To forecast size of market segments in North America, Europe, Asia Pacific, and RoW

# To strategically profile key players in the global market and comprehensively analyze their core competencies

# To track and analyze competitive developments such as mergers and acquisitions; product developments; agreements, partnerships and collaborations; and research and development activities in the market

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=347

Targeted Audience in This Study:

# Healthcare IT Providers

# Healthcare insurance companies/payers

# Healthcare institutions/providers (hospitals, medical groups, physician practices, diagnostic centers, and outpatient clinics)

# Research and development companies

# Government bodies and municipal corporations

# Business research and consulting service providers

# Venture capitalists

Factors Influencing Global Industry Growth:-

The key factors driving the growth of this market include increasing adoption of big data, wearable devices, and IoT in healthcare; advantages of cloud usage (such as improved storage, flexibility, and scalability of data); implementation of healthcare reforms such as the Patient Protection and Affordable Care Act; and the dynamic nature of health benefit plan design.

Restraints:

# Concerns Over Data Security and Privacy

# Migration from Legacy Systems is considered as A Tedious Task by Providers

Challenges:

# Issues Related to the Interoperability of Cloud

Key Market Opportunities:

# Emergence of Telecloud

# Formation of Accountable Care Organizations

Industry’s Revenue Growth Expectations:

The global healthcare cloud computing market is expected to reach USD 44.93 billion by 2023 from USD 19.46 billion in 2018, at a CAGR of 18.2%.

Geographical Growth Scenario:

In 2018, North America held the largest share of the healthcare cloud computing market, followed by Europe. Factors such as the increasing adoption of EHRs among medical professionals and active participation by private sector players in the development of the healthcare industry in that region are contributing to the dominant share of this region.

Read More: 

https://www.marketsandmarkets.com/Market-Reports/cloud-computing-healthcare-market-347.html

Leading Market Players:

# CareCloud Corporation (US)

# ClearData Networks Inc. (US)

# Athenahealth (US)

# Cerner Corporation (US)

# Epic Systems Corporation (US)

# NextGen Healthcare (US) and many more…

Agreements, partnerships, collaborations, alliances, expansions, acquisitions, and product launches were the major strategies adopted by key players to achieve growth in this market. Agreements, partnerships, collaborations, and alliances accounted for 45.3% of the total strategies adopted by the players in this market.

Product launches accounted for 21.7% of the total strategies adopted by the players in the healthcare cloud computing market from 2015–2018. Players adopted this strategy to strengthen their existing product portfolios, increase their global presence, and enhance customer experience.

Global Healthcare IT Industry - Emerging Trends to Look Forward to...

This study involved four major activities in estimating the current size of the healthcare IT market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the sizes of segments and subsegments.

Recent Developments:

# In 2019, Philips launched Cares Aging & Caregiving service.

# In 2018, Change Healthcare launched Dx Gap Advisor

# In 2017, Optum acquired DaVita Medical Group (US). The acquisition of DaVita enhanced Optum’s physician-led primary, specialty, in-home, and surgery-care delivery services business.

# In 2017, Cognizant acquired TMG Health (US) to expand its business process-as-a-service solutions for government and public health programs

# In 2018, Optum collaborated with Humana (US), MultiPlan (US) and Quest Diagnostics (US) to form a group to explore the blockchain technology to improve data quality and reduce administrative costs in healthcare

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252

Key Questions Addressed in the Report:

# Who are the top 10 players operating in the healthcare IT market?

# What are the driving factors, restraints, opportunities, and challenges in the market?

# What are the industry trends as well as the current scenario in the healthcare IT market?

# What are the growth trends in the market at the segmental and overall market levels?

Factors Influencing Global Industry Growth:-

The demand for healthcare IT solutions and services is driven by government mandates & support for healthcare IT solutions, rising use of big data in healthcare, high returns on investment for healthcare IT solutions, and the need to curtail escalating healthcare costs. However, IT infrastructural constraints in developing countries are expected to restrain the growth of this market during the forecast period.

Restraints:

# IT Infrastructural Constraints in Developing Countries

Challenges:

# Security Concerns

# Interoperability Issues

Key Market Opportunities:

# Rising Use of Healthcare IT Solutions in Outpatient Care Facilities

# Growing Mhealth, Telehealth, and Remote Patient Monitoring Markets

# Cloud-Based EHR Solutions

# Shift towards Patient-Centric Healthcare Delivery

Industry’s Revenue Growth Expectations:

The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period.

Geographical Growth Scenario:

The Healthcare IT market is broadly segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Healthcare IT market in 2018. The large share of this region can be attributed to the technological competencies of healthcare industry and presence of well-established healthcare IT infrastructure in this regions.

Changing regulatory requirements for improving quality of healthcare and increasing patient safety and rising healthcare expenditures are some of the key factors driving the growth of the healthcare IT market in North America.

Read More:

https://www.marketsandmarkets.com/Market-Reports/healthcare-it-252.html

Leading Market Players:

# Optum (US)

# Cerner (US)

# Cognizant (US)

# Change Healthcare (US)

# Philips Healthcare (Netherlands)

# Epic Systems (US) and many more…

...That's Why We Need Technologically Advanced Vascular Access Devices | Major Industry Leaders

Objectives of the Study:

# To define, describe, and forecast the vascular access devices market by type, application, end user, and region

# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

# To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders

# To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

# To profile the key players and analyze their market shares and core competencies

# To track and analyze competitive developments such as product launches, approval, agreements, collaborations, and acquisitions in the global vascular access device market

Targeted Audience of This Study:

# Vascular access device manufacturers and distributors

# Interventional cardiology vascular device manufacturers

# Research and consulting firms

# Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)

# Research institutes

# Vendors/service providers

# Niche companies manufacturing novel vascular access devices

# Research and consulting firms

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122149686

Factors Influencing Global Industry Growth:-

The major drivers for the market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients.

Restraints:

# High Costs Involved in the Placement and Maintenance of Vascular Access Devices

# Product Recalls and Failures

Challenges:

# Shortage of Skilled Professionals

# Risks Associated With Vascular Access Devices

Opportunity:

# Technological Advancements

Industry’s Revenue Growth Expectations:

The global vascular access devices market is expected to reach USD 5.45 Billion by 2022 from USD 3.87 Billion in 2017, at a CAGR of 7.1%.

Geographical Growth Scenario:

North American segment is expected to account the largest share of the market in 2017. Market growth in this region is primarily driven by factors such as the high prevalence of cardiovascular diseases; increasing number of research studies and clinical trials for vascular access devices in the U.S.; and the increase in chemotherapy procedures.

Moreover, the increasing number of cardiac arrest cases, an increase in the number of minimally invasive procedures and the increase in cancer incidences in Canada are other factors driving the growth of this market in this region.

Read More: 

https://www.marketsandmarkets.com/Market-Reports/vascular-access-device-market-122149686.html

Leading Market Players:

# Becton Dickinson and Company (U.S)

# C.R.Bard, Inc. (U.S.)

# Smiths Medical, Inc. (U.K.)

# Teleflex Incorporated (U.S.)

# B Braun Melsungen Ag (Germany)

# AngioDynamics (U.S.) and many more…